SepsisNeoCALMNCT06811428
Neonatal Comfort Seat Allowing Safe Lumbar Puncture and Minimizing Failure: a Randomized Controlled Trial
A study testing A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS) in people with Sepsis and Meningitis, run by Joel Cox.
Trial summary
A research trial which compares standard of care against employing a novel device for immobilization of babies undergoing upright LP, the present working name for the device is LP Comfort Seat (LPCS). Read more about this study
- Who is it for?
- Ages 0 to 28 days
- Conditions the study is for
- Sepsis, Meningitis
- What is being tested?
- A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 68 participants
- Where
- No sites listed yet
- Study dates
- 1 Mar 2025to 1 Apr 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 28 days
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Late preterm (34 + weeks) Gestational Age to Term (42+ weeks GA)
- Weight of 2.5 - 5 kg
Who cannot join
- Any contraindication to having a lumbar punture procedure
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
Joel B Cox, Principle Investigator and Sponsor, Doctor of Medicine contact
About this study
A research trial which compares standard of care against employing a novel device for immobilization of babies undergoing upright LP, the present working name for the device is LP Comfort Seat (LPCS).
The research question is:
Read more
P: In late-preterm to term babies who are 0-28 days and undergoing LP for R/O Sepsis I: Is the LPCS more effective C: Than human/RN assisted upright positioning O: In generating a higher rate of first attempt LP success
Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)
Secondary outcome measures could include
- A qualitatively unadulterated tap (no blood) although as you know this is hard to control even with perfect positioning and technique and single pass
- A difference in FLACC score as measure of overall pain/comfort between test and control
Read the detailed description
Lay Description: Newborn babies who are unwell sometimes need to undergo a medical procedure known as a 'lumbar puncture' (also called 'spinal tap'). During this procedure, a needle is inserted at the base of the spine to extract fluid from the spinal column. This is most often done to determine if the baby has meningitis. The medical device presented here places the child's comfort and safety at the center of the spinal tap/ lumbar puncture experience and in doing increases the success of this otherwise stressful and technically challenging procedure. This is achieved by placing the child in a stable, firm, but comfortable position nearly eliminating patient motion which otherwise interferes with procedure success, and reduces the variability associated with a human assistant/holder
In the course of routine medical care of infants and young children, it may be necessary to conduct a procedure known as a 'lumbar puncture' or 'spinal tap' which involves insertion of a needle into the base of the spinal column in order to extract fluid for diagnostic purposes. The goal is to obtain a fluid sample with minimal trauma on the first attempt. The target space into which the operator is aiming to access this fluid is approx. 3 mm in diameter. First attempt failure rates range from 30-50%. A second try immediately following a first try, even if successful, leads to more trauma to the patient and often a sub-optimal sample (the "bloody tap") due to surrounding tissue/vascular disruption.
Many factors may contribute to first attempt success in this procedure:
- The clinical condition of the baby including hydration
- How well pain is controlled (assisting in the reduction of movement)
- The experience and confidence of the operator conducting the procedure and technique
- The experience of the assistant positioning the baby. This factor is generally accepted among clinicians as the most important factor contributing to procedure outcome and yet it is highly variable.
The lumbar puncture procedure may be conducted with the baby placed in a side-lying position. The side-lying position is most common, historically, as the patient seems to be more stable. However the alignment of the spine is often disrupted.
The upright sitting position may also be used. There is recent compelling evidence that this position is superior to the side lying position (NeoCLEAR Study 2023)
The sitting position is associated with better outcomes but is often avoided as the holding technique is more complex
The problem which the current innovation seeks to resolve is the high degree of variability in quality, consistency, and reproducibility of a positioning/immobilization of the neonatal patient during the lumbar puncture procedure.
- Conditions
- Sepsis, Meningitis
- Being tested
- A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS), Standard of Care (SOC)
- Keywords
- Lumbar puncture, Seating device, Positioning device, Newborn, Neonatal, Meningitis, Sepsis
- Medical subject headings
- Sepsis, Meningitis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)Device
The participant will be placed in the LPCS for their lumbar puncture procedure
Standard of Care (SOC)Other
The patient will be held in the upright position by a human assistant
| Study group | Role | What they receive |
|---|---|---|
| Lumbar Puncture Comfort Seat Arm | Experimental | This is the group that will have the lumbar puncture conducted in an upright sitting position assisted by the medical device Receives: Device: A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS) |
| Standard of Care Arm | Active comparator | This is the group that will have the lumbar puncture conducted in an upright sitting position assisted by the human assistant which is present standard of care Receives: Other: Standard of Care (SOC) |
What is being measured
The primary outcome is the main question the study is designed to answer.
First attempt LP success
Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)
Measured: Assessed at each procedure
Secondary outcomes (2)
Clear tap
A qualitatively unadulterated tap (no blood)
Measured: Assessed at each procedure
FLACC Score
A difference in FLACC score as measure of overall pain/comfort between test and control
Measured: Assessed at each procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2025
- Study start1 Mar 2025 (estimated)
- Primary completion1 Mar 2026 (estimated)
- Study completion1 Apr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for SepsisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 68 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Joel Cox
- Sponsor type
- University, hospital or other
- Collaborators
- Nova Scotia Health Authority
- Responsible party
- Sponsor-investigator, Joel Cox, Nova Scotia Health Authority
- Investigators
- Joel B Cox, Medical Doctor, Principal investigator, Nova Scotia Health Authority
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06811428
- Sponsor's protocol ID
- LPCSRCT2025
- Acronym
- NeoCALM
- Status last verified
- Jan 2025
- First submitted
- 31 Jan 2025
- Last updated
- 6 Feb 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Marshall ASJ, Sadarangani M, Scrivens A, Williams R, Yong J, Bowler U, Linsell L, Chiocchia V, Bell JL, Stokes C, Santhanadass P, Adams E, Juszczak E, Roehr CC; 'The NeoCLEAR Collaborative Group'. Study protocol: NeoCLEAR: Neonatal Champagne Lumbar punctures Every time - An RCT: a multicentre, randomised controlled 2 x 2 factorial trial to investigate techniques to increase lumbar puncture success. BMC Pediatr. 2020 Apr 15;20(1):165. doi: 10.1186/s12887-020-02050-8.
PubMed 32295554
Study at a glance
From the registry record, last updated by the sponsor on 6 Feb 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Neonatal Comfort Seat Allowing Safe Lumbar Puncture and Minimizing Failure: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06811428
- Acronym / sponsor ID
- NeoCALM / LPCSRCT2025
- Conditions
- Sepsis, Meningitis
- Keywords
- Lumbar puncture, Seating device, Positioning device, Newborn, Neonatal, Meningitis, Sepsis
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 68 participants (estimated)
- Lead sponsor
- Joel CoxUniversity, hospital or other
- Collaborators
- Nova Scotia Health Authority
- Study start
- 1 Mar 2025 (estimated)
- Primary completion
- 1 Mar 2026 (estimated)
- Study completion
- 1 Apr 2026 (estimated)
- First posted
- 6 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A research trial which compares standard of care against employing a novel device for immobilization of babies undergoing upright LP, the present working name for the device is LP Comfort Seat (LPCS).
The research question is:
P: In late-preterm to term babies who are 0-28 days and undergoing LP for R/O Sepsis I: Is the LPCS more effective C: Than human/RN assisted upright positioning O: In generating a higher rate of first attempt LP success
Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)
Secondary outcome measures could include
- A qualitatively unadulterated tap (no blood) although as you know this is hard to control even with perfect positioning and technique and single pass
- A difference in FLACC score as measure of overall pain/comfort between test and control
Detailed description
Lay Description: Newborn babies who are unwell sometimes need to undergo a medical procedure known as a 'lumbar puncture' (also called 'spinal tap'). During this procedure, a needle is inserted at the base of the spine to extract fluid from the spinal column. This is most often done to determine if the baby has meningitis. The medical device presented here places the child's comfort and safety at the center of the spinal tap/ lumbar puncture experience and in doing increases the success of this otherwise stressful and technically challenging procedure. This is achieved by placing the child in a stable, firm, but comfortable position nearly eliminating patient motion which otherwise interferes with procedure success, and reduces the variability associated with a human assistant/holder
In the course of routine medical care of infants and young children, it may be necessary to conduct a procedure known as a 'lumbar puncture' or 'spinal tap' which involves insertion of a needle into the base of the spinal column in order to extract fluid for diagnostic purposes. The goal is to obtain a fluid sample with minimal trauma on the first attempt. The target space into which the operator is aiming to access this fluid is approx. 3 mm in diameter. First attempt failure rates range from 30-50%. A second try immediately following a first try, even if successful, leads to more trauma to the patient and often a sub-optimal sample (the "bloody tap") due to surrounding tissue/vascular disruption.
Many factors may contribute to first attempt success in this procedure:
- The clinical condition of the baby including hydration
- How well pain is controlled (assisting in the reduction of movement)
- The experience and confidence of the operator conducting the procedure and technique
- The experience of the assistant positioning the baby. This factor is generally accepted among clinicians as the most important factor contributing to procedure outcome and yet it is highly variable.
The lumbar puncture procedure may be conducted with the baby placed in a side-lying position. The side-lying position is most common, historically, as the patient seems to be more stable. However the alignment of the spine is often disrupted.
The upright sitting position may also be used. There is recent compelling evidence that this position is superior to the side lying position (NeoCLEAR Study 2023)
The sitting position is associated with better outcomes but is often avoided as the holding technique is more complex
The problem which the current innovation seeks to resolve is the high degree of variability in quality, consistency, and reproducibility of a positioning/immobilization of the neonatal patient during the lumbar puncture procedure.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Lumbar Puncture Comfort Seat Arm | Experimental | Device: A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)This is the group that will have the lumbar puncture conducted in an upright sitting position assisted by the medical device |
| Standard of Care Arm | Active comparator | Other: Standard of Care (SOC)This is the group that will have the lumbar puncture conducted in an upright sitting position assisted by the human assistant which is present standard of care |
Who may qualify
- Ages
- 0 to 28 days
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (2 listed)
- Late preterm (34 + weeks) Gestational Age to Term (42+ weeks GA)
- Weight of 2.5 - 5 kg
Key exclusion criteria (1 listed)
- Any contraindication to having a lumbar punture procedure
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)The participant will be placed in the LPCS for their lumbar puncture procedure | Device | Lumbar Puncture Comfort Seat Arm |
| Standard of Care (SOC)The patient will be held in the upright position by a human assistant | Other | Standard of Care Arm |
Primary outcome
First attempt LP success
Time frame: Assessed at each procedure
Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)
2 secondary outcomes
Clear tap
Time frame: Assessed at each procedure
FLACC Score
Time frame: Assessed at each procedure
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Feb 2025.
- Background: PubMed 32295554Marshall ASJ, Sadarangani M, Scrivens A, Williams R, Yong J, Bowler U, Linsell L, Chiocchia V, Bell JL, Stokes C, Santhanadass P, Adams E, Juszczak E, Roehr CC; 'The NeoCLEAR Collaborative Group'. Study protocol: NeoCLEAR: Neonatal Champagne Lumbar punctures Every time - An RCT: a multicentre, randomised controlled 2 x 2 factorial trial to investigate techniques to increase lumbar puncture success. BMC Pediatr. 2020 Apr 15;20(1):165. doi: 10.1186/s12887-020-02050-8.
- Individual participant dataSharing planned: No
Related trials for Sepsis
Not yet recruitingPhase 2/3
A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial
Streptococcus Agalactiae Infection, Neonatal Sepsis
Active, not recruiting
CT for Personalized Mechanical Ventilation
Ventilator-Induced Lung Injury, Sepsis Syndrome
RecruitingPhase 4
A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients
Infection, Sepsis
Not yet recruiting
Double Plasma Separation and Adsorption in Acute-on-Chronic Liver Failure (DPMAS-ACLF Trial)
Acute-on-Chronic Liver Failure (ACLF)
Active, not recruitingPhase 4
Thymosin Alpha 1 and IgM Levels in Sepsis
Sepsis, Septic Shock
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Joel B Cox, Principle Investigator and Sponsor, Doctor of Medicine contact
Joel B Cox, Medical Doctor principal investigator
Nova Scotia Health Authority
Questions about this trial
What is this clinical trial studying?
A study testing A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS) in people with Sepsis and Meningitis, run by Joel Cox.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 6 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Joel B Cox, Principle Investigator and Sponsor, Doctor of Medicine (+19029664400, Joel.Cox@gatewaypaeds.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
First attempt LP success (time frame: Assessed at each procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06811428, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2025.